Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0027960 (
mole
)
21,279
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Purified mouse
nerve growth factor
(
NGF
)radiolabeled with 125I was tested for its ability to bind to a variety of different cultured cells.
NGF
binds readily to human and hamster melanoma cells but does not bind to many other cell lines. The three cell lines with the highest number of
NGF
receptors were derived from metastatic melanomas. One of these lines, A875, was studied in detail and was shown to have approximately 7x10(5)
NGF
receptors per cell with an association constant of 1.0x10(9) liters/
mole
. The use of these cells in competition binding assays permits the detection of 0.25 ng of
NGF
in various biologic fluids.
NGF
can be shown to increase the survival, but not the division, of melanoma cells maintained in medium depleted of serum growth factors. This effect of
NGF
as a specific "survival factor" appears analogous to its effect on cultured sympathetic ganglion cells and on other cells derived from the neural crest.
...
PMID:Nerve growth factor receptors on human melanoma cells in culture. 26 22
RNA synthesis in melanocytes and
nevus
cells, and the proliferation of those cells in the presence of
nerve growth factor
(
NGF
) and 12-0-tetradecanoyl-phorbol-13-acetate (TPA), were found to correlate with the amount of
NGF
bound to the chromatin versus the total internalized
NGF
(n/c
NGF
= nuclear/cellular ration). In
nevus
cells and in melanocytes of the early passages (n/c
NGF
= 0.16-0.18),
NGF
slightly activated RNA synthesis but was without any effect on cell growth. At passage 5-6 of melanocytes (n/c
NGF
= 0.88),
NGF
inhibited RNA synthesis, which led to inhibition of cell growth. Removal of TPA from the culture of
nevus
cells resulted in increased n/c
NGF
ratio and in a switch from activatory to inhibitory action of
NGF
. The possibility that the cell surface receptor mediated the stimulatory effect of
NGF
and may antagonize the chromatin receptor-mediated inhibitory effect of
NGF
of melanocyte and
nevus
cell growth is discussed.
...
PMID:Nerve growth factor chromatin receptor and cell surface receptor-regulated growth of melanocytes and nevus cells. 127 47
Immunohistochemical localization of
nerve growth factor
(
NGF
) receptor in normal skin and melanocytic tumor was analysed using monoclonal antibody. In normal skin and fetal skin NGF receptor was good marker for cutaneous nerve sheath and schwann cells. In melanocytic lineage, the NGF receptor was not expressed in fetal, normal and dermal melanocyte and weakly positive in only small part of
nevus
cell nest. Positive staining was seen in primary and metastatic melanoma lesion and restricted to melanoma cell membrane. The distribution of the receptor suggests that the
NGF
-receptor may be involved in the control of proliferation and malignant transformation in melanocytic lineage.
...
PMID:[Expression of nerve growth factor-receptor in normal skin and melanocytic tumor]. 216 92
The murine
nerve growth factor
, when injected i.v. or, combined in vitro with plasma, was found largely associated with the mouse alpha-macroglobulin (a homologue of human alpha 2-macroglobulin). The
nerve growth factor
-alpha-macroglobulin complex produced is sufficiently stable to resist separation by gel filtration in 1.0 M sodium chloride, polyacrylamide gel electrophoresis, and immunoprecipitation by antibodies against alpha-macroglobulin. As determined by equilibrium binding studies and computer generated Scatchard analysis, alpha-macroglobulin apparently possesses two types of binding sites with the apparent dissociation constants of 1.2 x 10(-6) and 2.9 x 10(-9) M, respectively, saturable by 3.7 and 0.03 moles of
nerve growth factor
. Hence, about one
mole
of
nerve growth factor
is bound to each of the four subunits of alpha-macroglobulin. Nerve growth factor can be readily dissociated from alpha-macroglobulin in sodium dodecyl sulfate gel electrophoresis in the absence of a reductant. Procedures that affect the proteinase-binding or methylamine- activities of alpha-macroglobulin do not affect the binding of
nerve growth factor
, and the binding is unaffected by the presence of zinc ions or EDTA. Hence,
nerve growth factor
is noncovalently associated with alpha-macroglobulin at a site separate from that of the proteinase-, methylamine-, and zinc-binding sites of alpha-macroglobulin. Mouse alpha-macroglobulin can protect the
nerve growth factor
from inactivation by trypsin. Even in the presence of trypsin, alpha-macroglobulin-
nerve growth factor
complexes still can stimulate the neurite outgrowth by dorsal root ganglia of 9-day-old chicken embryos. Since alpha-macroglobulin can specifically and noncovalently carry
nerve growth factor
, one important role of this alpha-macroglobulin in the circulation and extracellular spaces may be to protect the
nerve growth factor
from proteinase inactivation.
...
PMID:Interaction of nerve growth factor with murine alpha-macroglobulin. 246 89
7S
nerve growth factor
(7S NGF) and
nerve growth factor
I (NGFI) are NGF-containing protein complexes isolated from mouse submandibular glands by different protocols, and reports suggest that the molecules differ chemically. In this study, we compared the molecular properties and subunit compositions of the two proteins. Purified 7S NGF and NGFI electrophoresed to identical positions on polyacrylamide gels in nondissociating buffers, with electrophoretic mobilities indistinguishable from that of unpurified NGF in salivary gland extracts. Ultraviolet absorption curves were identical, and sedimentation coefficients were similar (7.3 +/- 0.25 S for 7S NGF; 7.2 +/- 0.2 S for NGFI) as determined by sedimentation velocity analysis. By sedimentation equilibrium analysis, molecular weights of 135 000-140 000 were obtained for both complexes at protein concentrations in the centrifuge cell greater than 85 micrograms/mL; when protein concentrations within the centrifuge cell ranged from approximately 30 to 100 micrograms/mL at equilibrium, both complexes dissociated. Molecular weight values determined by gel filtration on Bio-Gel P300 and Sephadex G200 resins were similar for both proteins, and the values determined on Sephadex agreed with those obtained by ultracentrifugation. The subunit compositions of the complexes were also similar as determined by nonequilibrium isoelectric focusing, NGFI being composed of proteins that migrated to positions identical with those of the alpha, beta, and gamma subunits of 7S NGF. Furthermore, the stoichiometry of the subunits was similar in the two complexes as determined by radioimmunoassays to each of the subunits and by densitometric analysis of electrophoretic gels. Both methods showed that the complexes contain approximately 2 mol of the alpha and gamma subunits per
mole
of beta-NGF.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Comparison of 7S nerve growth factor and nerve growth factor I from mouse submandibular glands. 396 41
Iodination of the beta nerve growth factor protein up to 4.1 iodines per
mole
of
nerve growth factor
was achieved with no loss of biological activity. At this level of incorporation no native or monoiodo
nerve growth factor
remained, the major species being the tri- and tetraiodo derivatives. An (125)I-labeled beta nerve growth factor of high specific activity containing 0.5 iodine per
mole
of beta nerve growth factor was used to determine the specific binding of
nerve growth factor
to dorsal root ganglion cells of 8-day-old embryonic chicks. The specific binding of (125)I-labeled
nerve growth factor
reached saturation at 30-50 ng/ml and half-saturation at 7-8 ng/ml (0.26 nM). The number of receptors per responsive medio-dorsal cell was calculated to be about 2 x 10(4). The pattern of displacement of bound (125)I-labeled beta nerve growth factor by native beta nerve growth factor showed that the two proteins had identical affinities for the receptor. The specificity of the binding for beta nerve growth factor was demonstrated by the fact that only native beta nerve growth factor displaced the bound (125)I-labeled form. Partially inactivated derivatives of beta nerve growth factor retained the same fraction of their specific-binding capacity as of their biological activity. The specificity of the binding for cell type was shown by the lack of any specific component of (125)I-labeled beta nerve growth factor binding to liver or brain cells. The rate constant for association of beta nerve growth factor with its receptor, k(1), was 1.0 x 10(7) mol(-1) sec(-1) and the rate constant for dissociation, k(-1), 1.2 x 10(-8) sec(-1).
...
PMID:Properties of the beta nerve growth factor receptor of avian dorsal root ganglia. 435 93
The
nerve growth factor
(
NGF
) receptor was characterized by using a new series of anti-receptor monoclonal antibodies (MAbs). These MAbs (i) showed significantly greater reactivity with a melanoma cell line expressing higher levels of NGF receptor, (ii) inhibited the binding of 125I-labeled
NGF
to its receptor, and (iii) immunoprecipitated both metabolically labeled and 125I-labeled
NGF
affinity-labeled receptor. These experiments defined the receptor as a 75-kDa cell-surface protein. The NGF receptor was visualized by immunoperoxidase staining in tissue sections of human
nevi
, melanomas, neurofibromas, a pheochromocytoma, and peripheral nerves. Uniform staining of the cytoplasm suggests that, in addition to cell-surface
NGF
receptors, there is a population of intracellular receptors.
...
PMID:Characterization of nerve growth factor receptor in neural crest tumors using monoclonal antibodies. 609 11
Methylamine-modified alpha-2-macroglobulin (MA-alpha 2M) has been recently shown to inhibit the biological activity of beta-nerve growth factor (
NGF
) in promoting neurite outgrowth by embryonic dorsal root ganglia in culture (Koo PH, Liebl DJ, J Neurosci Res 31:678-692, 1992). The objectives of this study are to determine whether alpha 2M can also be modified by larger aromatic biogenic amines such as 5-hydroxytryptamine (5HT; serotonin), the nature of interaction between
NGF
and 5HT-modified alpha-2-M (5HT-alpha 2M), and the effect of 5HT-alpha 2M on the neurite extension and the growth of embryonic sensory and cholinergic neurons in 2 disparate animal species (chicken and rats). This study demonstrates that each
mole
of alpha 2M can combine with 15.2 +/- 1.8 moles of 5HT, in which up to 4.5 +/- 0.4 moles may be covalently bonded. As determined by gel filtration and polyacrylamide gel electrophoresis studies, both 5HT-alpha 2M and normal alpha 2M combine noncovalently with
NGF
, but 5HT-alpha 2M by comparison can combine with
NGF
somewhat more effectively. In contrast to normal alpha 2M, 5HT-alpha 2M at concentrations greater than about 0.17 microM exerts a dose-dependent inhibition on the
NGF
-stimulated neurite outgrowth by embryonic dorsal root ganglia and dissociated cells in culture, and the inhibitory effect can be overcome by higher
NGF
concentrations. Both 5HT-alpha 2M and MA-alpha 2M at 1.0 microM inhibit neurite extension by embryonic rat cerebral cortical cells and seriously damage these cells in culture. Such neurite-inhibitory activity, however, can only be partially blocked by extraneously added
NGF
alone. Normal alpha 2M (at 1.0 microM) and 5HT (at 188 microM), on the other hand, under the identical conditions produce very little or no effect on the normal cellular and axonal growth of these cells. We conclude that alpha 2M can potentially interact with nucleophilic monoamines, including neurotransmitters, to form inhibitory complexes which may inhibit/regulate
NGF
-promoted neurite outgrowth and neuronal survival. In addition, higher concentrations of such complexes can seriously damage certain CNS neurons which do not depend solely on
NGF
for survival.
...
PMID:Serotonin-activated alpha 2-macroglobulin inhibits neurite outgrowth and survival of embryonic sensory and cerebral cortical neurons. 768 85
The histogenesis of "nevic corpuscles" (NCs) in neural
nevi
is still controversial. Recent studies have revealed that nerve growth factors (NGFs) and other growth factors [that is, epidermal growth factor (EGF)] could have various paracrine and autocrine functions on Schwann cells and melanocytes. We examined the immunohistochemical expression of
NGF
and EGF receptors (r) in 15 cases of neural
nevi
containing NCs along with 37 cases of other benign and malignant melanocytic lesions without neural differentiation (total, 52). Section were prepared from formalin-fixed and paraffin-embedded tissues. Monoclonal antibodies to NGFr and EGFr were used with the Avidin-biotin-complex (ABC) technique. We found strong reactivity for NGFr in 14 of 15 neural
nevi
with a predilection for NCs, but only eight of 37 were positive in the other group of melanocytic lesions without neural differentiation (four Spitz
nevi
, two melanomas, and two compound
nevi
). EGFr expression was limited mainly to NCs in four cases of neural
nevi
. We conclude that neural differentiation and NC formation are associated with NGFr overexpression, whereas EGFr expression is only limited. The relative paucity of NGFr expression in other type of benign and malignant melanocytic lesions supports the view that neural "differentiation" is a distinct process in certain long-standing melanocytic
nevi
. We postulate that NGFr overexpression may be the result of the reactivation of oncofetal genes that could become manifest in either abnormal schwannian differentiation (as seen in neural
nevi
), in a neoplastic context (as seen in neural and melanocytic tumors).
...
PMID:Expression of nerve growth factor and epidermal growth factor receptors in neural nevi with nevic corpuscles. 890 91
Aluminum inactivated glutamate dehydrogenase (GDH) by a pseudo-first-order reaction at micromolar concentrations. A double-reciprocal plot gave a straight line with a k(inact) of 2.7 min(-1) and indicated the presence of a binding step prior to inactivation. The inactivation was strictly pH dependent and a marked increase in sensitivity to aluminum was observed as the pH decreased. At a pH higher than 8.5, no inactivation was observed. The completely inactivated GDH contained 2 mol of aluminum per
mole
of enzyme subunit monomer. When preincubated with enzyme, several chelators such as citrate, NaF, N-(2-hydroxyethyl) ethylenediaminetriacetic acid or ethylenediaminetriacetic acid efficiently protected the enzyme against the aluminum inactivation. In a related experiment, only citrate and NaF released the aluminum from the completely inactivated aluminum-enzyme complex and fully recovered the enzyme activity. Ferritin, NADP+, or
nerve growth factor
did not show any effects on the recovery of the aluminum-inactivated GDH activity. The dissociation constant for the aluminum-enzyme complex was calculated to be 5.3 microM. Although aluminum has been known to form a complex with nucleotides, no such effects were observed in the inactivation of GDH by aluminum as determined using GDHs mutated at the ADP-binding site, NAD+-binding site or GTP-binding site. Circular dichroism studies showed that the binding of aluminum to the enzyme induced a decrease in alpha helices and beta sheets and an increase in random coil. Therefore, inactivation of GDH by aluminum is suggested to be due to the conformational change induced by aluminum binding. These results suggest a possibility that aluminum-induced alterations in enzymes of the glutamate system may be one of the causes of aluminum-induced neurotoxicity.
...
PMID:Inactivation of human glutamate dehydrogenase by aluminum. 1462 97
1
2
Next >>